HMOX1 and breast carcinoma: Furthermore, previously published studies have shown that HO-1 is potentially linked to the chemo-resistance by blocking apoptosis and autophagy of breast cancer cells, and silencing HO-1 can sensitize these resistant cells to doxorubicin (Tan et al., 2015; Zhu et al., 2015).